These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report.
    Author: Ben Zvi M, Vaknine H, Menczer J, Peled O, Ben Shem E, Schreiber L, Levy T.
    Journal: Chemotherapy; 2016; 61(5):236-9. PubMed ID: 26928175.
    Abstract:
    Subacute cutaneous lupus erythematosus (SCLE) is a rare eruption related to several pharmacological and chemotherapy agents. We present a 63-year-old female with recurrent epithelial ovarian cancer who developed SCLE after administration of gemcitabine. Following discontinuation of gemcitabine and after oral steroid treatment, all skin lesions disappeared. In view of the extensive use of gemcitabine in recurrent ovarian cancer, it is important to be aware of the possibility of SCLE occurrence in these patients.
    [Abstract] [Full Text] [Related] [New Search]